Results 211 to 220 of about 88,359 (253)
Some of the next articles are maybe not open access.
Current Treatment Options in Gastroenterology, 2001
There is currently no effective treatment for patients with nonulcer dyspepsia. Helicobacter pylori eradication has no beneficial effect on dyspeptic symptoms. Proton pump inhibitors are superior to placebo in the subset of patients with epigastric pain as the predominant symptom. H(2 )Receptor antagonists have no effect. Patients with dysmotility-like
openaire +3 more sources
There is currently no effective treatment for patients with nonulcer dyspepsia. Helicobacter pylori eradication has no beneficial effect on dyspeptic symptoms. Proton pump inhibitors are superior to placebo in the subset of patients with epigastric pain as the predominant symptom. H(2 )Receptor antagonists have no effect. Patients with dysmotility-like
openaire +3 more sources
Current Opinion in Gastroenterology, 2004
Functional dyspepsia is a common disorder, most of the time of unknown etiology and with variable pathophysiology. Therapy has been and still is largely empirical. Data from recent studies provide new clues for targeted therapy based on knowledge of etiology and pathophysiologic mechanisms.The role of Helicobacter pylori gastritis in the pathogenesis ...
Kleibeuker, JH, Thijs, JC
openaire +3 more sources
Functional dyspepsia is a common disorder, most of the time of unknown etiology and with variable pathophysiology. Therapy has been and still is largely empirical. Data from recent studies provide new clues for targeted therapy based on knowledge of etiology and pathophysiologic mechanisms.The role of Helicobacter pylori gastritis in the pathogenesis ...
Kleibeuker, JH, Thijs, JC
openaire +3 more sources
Current Gastroenterology Reports, 2009
The prevalence of dyspepsia in the general population is as high as 40%, and its management represents a considerable financial burden to the health care system. Causes of dyspepsia amenable to medical therapy include peptic ulcer and functional dyspepsia, and testing for Helicobacter pylori and treating positive individuals is beneficial in both ...
Alexander C, Ford, Paul, Moayyedi
openaire +2 more sources
The prevalence of dyspepsia in the general population is as high as 40%, and its management represents a considerable financial burden to the health care system. Causes of dyspepsia amenable to medical therapy include peptic ulcer and functional dyspepsia, and testing for Helicobacter pylori and treating positive individuals is beneficial in both ...
Alexander C, Ford, Paul, Moayyedi
openaire +2 more sources
Current Opinion in Gastroenterology, 2016
Functional dyspepsia affects 10% of the population. Emerging data are beginning to unravel the pathogenesis of this heterogeneous disorder, and new data on treatment are helping to guide evidence-based practice. In this review, the latest advances are summarized and discussed.The Rome IV criteria were published in 2016 and are similar to Rome III but ...
Talley, Nicholas J. +2 more
openaire +3 more sources
Functional dyspepsia affects 10% of the population. Emerging data are beginning to unravel the pathogenesis of this heterogeneous disorder, and new data on treatment are helping to guide evidence-based practice. In this review, the latest advances are summarized and discussed.The Rome IV criteria were published in 2016 and are similar to Rome III but ...
Talley, Nicholas J. +2 more
openaire +3 more sources
Scandinavian Journal of Gastroenterology, 1995
Non-Ulcer Dyspepsia (NUD) is a very common problem which has many causes. Trying to group dyspeptic patients according to symptoms has been proposed in order to improve our understanding of the problem and to aid both clinical trials and indeed practice by studying and treating homogeneous groups.The literature has been reviewed to see if sub-groups of
openaire +2 more sources
Non-Ulcer Dyspepsia (NUD) is a very common problem which has many causes. Trying to group dyspeptic patients according to symptoms has been proposed in order to improve our understanding of the problem and to aid both clinical trials and indeed practice by studying and treating homogeneous groups.The literature has been reviewed to see if sub-groups of
openaire +2 more sources
1989
One third to one half of cases of dyspepsia remain unexplained. The cause of nonulcer dyspepsia is unknown, but aerophagia, esophageal dysfunction, pyloroduodenal dysmotility and the irritable bowel syndrome may be important factors in some patients. The symptoms are often affected by diet and emotion.
openaire +2 more sources
One third to one half of cases of dyspepsia remain unexplained. The cause of nonulcer dyspepsia is unknown, but aerophagia, esophageal dysfunction, pyloroduodenal dysmotility and the irritable bowel syndrome may be important factors in some patients. The symptoms are often affected by diet and emotion.
openaire +2 more sources
Current Gastroenterology Reports, 2002
Nonulcer dyspepsia is a common condition in clinical practice. It is a heterogeneous disorder, and no single therapeutic agent is effective in all patients. The treatment of nonulcer dyspepsia is still dissatisfactory. Eradication of Helicobacter pylori organisms has a limited role and little effect.
openaire +2 more sources
Nonulcer dyspepsia is a common condition in clinical practice. It is a heterogeneous disorder, and no single therapeutic agent is effective in all patients. The treatment of nonulcer dyspepsia is still dissatisfactory. Eradication of Helicobacter pylori organisms has a limited role and little effect.
openaire +2 more sources
Functional Dyspepsia: Diagnostic and Therapeutic Approaches
Drugs, 2020G. Sayuk, C. Gyawali
semanticscholar +1 more source
Primary Care: Clinics in Office Practice, 2007
Riza Tady, Conroy, Bushra, Siddiqi
openaire +2 more sources
Riza Tady, Conroy, Bushra, Siddiqi
openaire +2 more sources